REGN

Regeneron Pharmaceuticals, Inc. REGN

$676.69 -2.25 (-0.33%)

Extended · +1.46σ

+ Compare Open in Sniper

Mkt cap $69.5B

P/E 16.5

Day $672.31 – $691.13

52wk $591.52 – $815.00

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Regeneron Pharmaceuticals, Inc. is a healthcare company listed in the US.

REGN last traded at $676.69, down 0.3% on the day; that's in the middle part of its 52-week range ($591.52–$815.00). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 62), the trend is strong (ADX 31), and trading is light at 0.7× normal volume. On the business side, revenue is growing 19% year over year and the business keeps about 23 cents of every sales dollar as free cash.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI

0–100 · <30 oversold

Trend strength · ADX

>25 = strong trend

Volume vs avg

0.69×

1× = average

Stretch from avg

+1.4 ATR

− below · + above

Zone touches

tests of this zone

Suggested hold

3–30

bars (≈ days)

Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Revenue growth

+19.0%

year over year

Free-cash-flow margin

22.8%

cash kept per $ of sales

Debt / equity

0.09

lower = less leveraged

P/E ratio

16.5

price ÷ yearly profit

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $1311.92 (fair range $418–$1312); today's price leaves a +48% cushion below that estimate. The model's verdict is “Deep value” and accounting quality screens as Strong. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$1311.92

Fair-value range

$417.67 – $1311.92

Margin of safety

+48%

Verdict

Deep value

Accounting quality Strong

✓ More cash than debt
✓ Quick ratio 3.32 (antifragile)
✓ Current ratio 4.13 (antifragile)
✓ Debt/equity 0.30 (antifragile)

Price implies ~7% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

REGN is a $69.5 billion company, priced at 17× last year's earnings.

Mkt cap $69.5B

P/E ttm 16.5

Fwd P/E —

Beta —

Day range $672.31 – $691.13

52w range $591.52 – $815.00

Avg vol —

RSI(2) 73.5

ROE —

Net mgn —

FCF mgn 22.8%

Debt/Eq 0.09

Div yld —

Sector Healthcare

Industry Biotechnology

Next earn —

52-week range · today's price

$591.52$815.00